A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Clinical trial NCT06003426 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06003426
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2026-10-06
- Enrollment
- 1255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.